We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Upcoming European Drug Discovery Conference to Showcase State-of-the-Art Instrumentation

By LabMedica International staff writers
Posted on 05 Sep 2011
Print article
Image: The Eon Microplate Spectrophotometer (Photo courtesy of BioTek Instruments).
Image: The Eon Microplate Spectrophotometer (Photo courtesy of BioTek Instruments).
State-of-the-art liquid handling and microplate analysis instrumentation will be on display at an upcoming European drug-discovery conference.

BioTek Instruments, Inc. (Winooski, VT, USA) will highlight several of their newest microplate instrumentation technologies at the fifth annual Drug Discovery Conference, which is to be held on September 7-8, 2011 in Manchester, United Kingdom.

Among the instruments to be displayed is the Synergy 4, a multidetection system capable of performing an unlimited number of microplate-based assays, which combines two powerful fluorescence detection systems, monochromator-based and filter-based, in one compact unit. Filter-based fluorescence technology provides optimal light filtering and purification for the best sensitivity. The quadruple monochromator-based fluorescence technology offers flexible wavelength selection, true spectral scanning, reduced background noise, and increased convenience.

The Synergy H1 Hybrid Multi-Mode Microplate Reader is a flexible monochromator-based multimode microplate reader. The monochromator optics uses a third generation quadruple grating design that allows working at any excitation or emission wavelength with a one-nanometer step. This system supports top and bottom fluorescence intensity, UV-visible absorbance, and high performance luminescence detection. It can handle all the standard microplate applications found in life science research laboratories.

The Eon Microplate Spectrophotometer has continuous wavelength selection from 200 nm to 999 nm, selectable in one-nanometer increments. Eon reads 6- to 384-well microplate formats, and offers an optional cuvette port. The instrument boasts an extended incubation option to 65 °C. Eon comes with the advanced Gen5 v 2.0 software package and is compatible with Take3 Micro-Volume plates for two µL measurements.

The Multiflo Microplate Dispenser accommodates microplate types ranging from 6- to 1,536-wells, and dispenses volumes of from one to three microliters accurately and precisely. MultiFlo offers a choice of either peristaltic pump or microprocessor controlled syringe drive technologies, and the researcher can purchase one channel now and add others in the future. Angled dispensing ensures compatibility with all dispense protocols including media exchanges with loosely adherent cell monolayers. For assays requiring minimum reagent usage, the MultiFlo's prime volume is less than one milliliter. A built-in priming trough is designed to allow both recovery of reagents or to send primed reagent directly to waste.

In addition, this conference marks the European debut of BioTek's ELx405 Select Deep Well Washer. This full plate washer automates aspirate and dispense steps in 96- and 384-well deep well microplates up to 50 mm high for increased washing efficiency compared to manual or hand-held methods.

Related Links:

BioTek Instruments, Inc.



Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Urine Bone Markers Control
Lyphochek Urine Bone Markers Control
New
Chlamydia Test Kit
CHLAMYTOP

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The artificial intelligence models can personalize immune therapies in oncology patients (Photo courtesy of 123RF)

AI Tool Identifies Novel Genetic Signatures to Personalize Cancer Therapies

Lung cancer and bladder cancer are among the most commonly diagnosed cancers globally. Researchers have now developed artificial intelligence (AI) models designed to personalize immune therapies for oncology... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.